TGTR.TA TLV
Together Pharma Ltd.
1W: +0.7%
1M: -6.9%
3M: -13.8%
YTD: -39.5%
1Y: -44.8%
3Y: -26.9%
5Y: -91.9%
₪207.60 ($0.68)
+2.90 (+1.42%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$96M
+5.5% ▲
Gross Profit
$18M
-49.4% ▼
Operating Income
$3M
-85.2% ▼
Net Income
-$1M
+72.8% ▲
EPS (Diluted)
$-0.09
+80.8% ▲
EBITDA
$9M
-67.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $11M | $12M | $31M | $91M | $96M |
| YoY Growth | +0.0% | +4.1% | +169.6% | +191.4% | +5.5% |
| Cost of Revenue | $17M | $14M | $37M | $56M | $79M |
| Gross Profit | -$6M | -$2M | -$6M | $35M | $18M |
| Gross Margin | -52.5% | -18.8% | -18.9% | 38.0% | 18.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11M | $10M | $12M | $13M | $14M |
| Operating Expenses | $12M | $9M | $14M | $13M | $14M |
| Operating Income | -$7M | -$16M | -$6M | $22M | $3M |
| Operating Margin | -67.1% | -140.1% | -20.1% | 24.3% | 3.4% |
| Interest Expense | $12M | $15M | $17M | $20M | $10M |
| Income Before Tax | $14M | -$15M | -$36M | $2M | -$2M |
| Tax Expense | -$1M | -$12M | -$847K | $4M | -$592K |
| Net Income | $7M | -$14M | -$34M | -$4M | -$1M |
| Net Margin | 64.3% | -119.0% | -107.4% | -4.7% | -1.2% |
| EPS (Diluted) | $1.24 | $-2.01 | $-4.11 | $-0.49 | $-0.09 |
| EBITDA | $21M | -$6M | -$14M | $28M | $9M |
| Shares Outstanding | 6M | 7M | 8M | 9M | 12M |